Taro Pharmaceutical Industries Ltd (TARO)
42.23
+0.03
(+0.07%)
USD |
NYSE |
Apr 25, 10:58
Taro Pharmaceutical Industries Gross Profit Margin (Quarterly): 50.83% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.83% |
| September 30, 2023 | 49.66% |
| June 30, 2023 | 40.33% |
| March 31, 2023 | 51.65% |
| December 31, 2022 | 46.01% |
| September 30, 2022 | 35.99% |
| June 30, 2022 | 52.09% |
| March 31, 2022 | 53.99% |
| December 31, 2021 | 54.71% |
| September 30, 2021 | 47.01% |
| June 30, 2021 | 52.82% |
| March 31, 2021 | 51.86% |
| December 31, 2020 | 52.22% |
| September 30, 2020 | 57.12% |
| June 30, 2020 | 55.21% |
| March 31, 2020 | 58.46% |
| December 31, 2019 | 63.74% |
| September 30, 2019 | 63.17% |
| June 30, 2019 | 63.07% |
| March 31, 2019 | 66.44% |
| December 31, 2018 | 66.64% |
| September 30, 2018 | 68.29% |
| June 30, 2018 | 64.73% |
| March 31, 2018 | 67.88% |
| December 31, 2017 | 66.20% |
| Date | Value |
|---|---|
| September 30, 2017 | 73.64% |
| June 30, 2017 | 72.24% |
| March 31, 2017 | 73.23% |
| December 31, 2016 | 75.93% |
| September 30, 2016 | 77.49% |
| June 30, 2016 | 78.19% |
| March 31, 2016 | 84.59% |
| December 31, 2015 | 82.90% |
| September 30, 2015 | 79.58% |
| June 30, 2015 | 79.81% |
| March 31, 2015 | 81.76% |
| December 31, 2014 | 81.40% |
| September 30, 2014 | 78.97% |
| June 30, 2014 | 65.55% |
| March 31, 2014 | 75.52% |
| December 31, 2013 | 80.74% |
| September 30, 2013 | 77.67% |
| June 30, 2013 | 69.66% |
| March 31, 2013 | 72.35% |
| December 31, 2012 | 75.35% |
| September 30, 2012 | 75.37% |
| June 30, 2012 | 71.69% |
| March 31, 2012 | 68.33% |
| December 31, 2011 | 71.60% |
| September 30, 2011 | 67.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
35.99%
Minimum
Sep 2022
63.74%
Maximum
Dec 2019
52.63%
Average
52.22%
Median
Dec 2020
Gross Profit Margin (Quarterly) Benchmarks
| InspireMD Inc | 28.68% |
| Ayala Pharmaceuticals Inc | -- |
| BiomX Inc | -- |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.63% |
| Return on Assets | 2.14% |
| Return on Invested Capital | 2.61% |
| Profit Margin (Quarterly) | 12.86% |
| Operating Margin (Quarterly) | 10.11% |
| Return on Net Operating Assets | 6.55% |